| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2026 | 22 May 2026 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday 28th May 2026 Outcome of the Board Meeting and Submission of the Audited Standalone Financial Results for the Half year and year ended March 31, 2026. (As Per BSE Announcement Dated on 28.05.2026) | ||
| Board Meeting | 5 May 2026 | 5 May 2026 |
| Outcome of the Board Meeting held on Tuesday, May 05, 2026 for conversion of 111000 warrants into 111000 equity shares of face value of Rs. 10/- | ||
| Board Meeting | 1 May 2026 | 1 May 2026 |
| Outcome of the Board Meeting held on Friday, May 01, 2026 for conversion of 114000 warrants in to Equity Shares | ||
| Board Meeting | 7 Mar 2026 | 7 Mar 2026 |
| Conversion of 2,79,000 warrants in to 2,79,000 Equity Shares | ||
| Board Meeting | 17 Nov 2025 | 17 Nov 2025 |
| Outcome of the Board Meeting held on Monday, November 17, 2025 considered and approved the conversion of 7,35,000 warrants into 7,35,000 equity shares of face value of Rs. 10/- (Rupees Ten Only) | ||
| Board Meeting | 15 Nov 2025 | 15 Nov 2025 |
| Outcome of the Board Meeting held on Saturday, November 15, 2025. | ||
| Board Meeting | 10 Nov 2025 | 5 Nov 2025 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve 1. To consider approve and take on record the Unaudited Financial Results for the half year ended on 30th September 2025 as per Regulation 33 of the SEBI (LODR) Regulation 2015; 2. Any other business with the permission of the chair and the majority of the directors presents at the meeting Outcome of the Board Meeting held on Monday, 10 November 2025 and Submission of the Unaudited Financial Results and Limited Review Report on Financial Result for the half year ended on 30th September, 2025 (As per BSE Announcement dated on: 10.11.2025) | ||
| Board Meeting | 16 Oct 2025 | 16 Oct 2025 |
| 8,61,000 Equity Shares allotted pursuant to conversion of warrants | ||
| Board Meeting | 3 Oct 2025 | 3 Oct 2025 |
| 11,28,000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants. | ||
| Board Meeting | 1 Oct 2025 | 1 Oct 2025 |
| 13,14,000 Equity Shares allotted Pursuant to Conversion of Warrants | ||
| Board Meeting | 2 Sep 2025 | 27 Aug 2025 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 inter alia to consider and approve the agenda items as mentioned in attached intimation Outcome of Board Meeting of The Company Held on the Tuesday, 02nd September, 2025 (As Per BSE Announcement Dated on: 02/09/2025) | ||
| Board Meeting | 6 Aug 2025 | 6 Aug 2025 |
| Outcome of Board Meeting dated 06th August, 2025 for Allotment of 88,08,000 Warrants | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
